Carrie Andrews
Family · Zanesville, OHNPI 1053635086
Payments from drug & device makers
Across 774 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- EMD Serono, Inc.$2K
- UCB, Inc.$1K
- Pfizer$1K
- Biohaven Pharmaceuticals, Inc.$823
- SK Life Science, Inc.$783
- plus $7K from 49 others
What the payments were for
- Consulting fees$6954%
- Speaking & faculty fees$4,27525%
- Food & beverage$12,01770%
- Education$2912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,278 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 12 | $234,556 |
| XcopriCenobamate | 66 | $141,825 |
| Avonex (4 Pack)Interferon Beta-1a | 13 | $121,583 |
| AubagioTeriflunomide | 11 | $101,155 |
| BriviactBrivaracetam | 55 | $86,454 |
| CopaxoneGlatiramer Acetate | 13 | $74,599 |
| Nurtec OdtRimegepant Sulfate | 39 | $71,279 |
| NuplazidPimavanserin Tartrate | 12 | $59,957 |
| FycompaPerampanel | 29 | $36,991 |
| NayzilamMidazolam | 35 | $32,075 |
| QuliptaAtogepant | 19 | $24,893 |
| LamictalLamotrigine | 13 | $23,966 |
| Emgality PenGalcanezumab-Gnlm | 22 | $23,410 |
| VimpatLacosamide | 21 | $22,677 |
| UbrelvyUbrogepant | 19 | $22,416 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SK Life Science, Inc.Xcopri | $783 | $141,82566 claims |
| UCB, Inc.Briviact, Nayzilam, Vimpat | $1,438 | $141,206111 claims |
| BiogenAvonex (4 Pack) | $509 | $121,58313 claims |
| SanofiAubagio | $165 | $101,15511 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $328 | $74,59913 claims |
| PfizerNurtec Odt, Dilantin | $1,063 | $73,86651 claims |
| Acadia Pharmaceuticals IncNuplazid | $155 | $59,95712 claims |
| AbbVieQulipta, Ubrelvy | $4,346 | $47,31038 claims |
| Eisai Inc.Fycompa | $421 | $36,99129 claims |
| Amneal Pharmaceuticals LLCRytary | $155 | $13,95011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.
Other family in Zanesville
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.